Microbiome overview
Community composition and measured biological features.
FOR CLINICIANS & RESEARCHERS
Neurabi aims to organise microbiome research into interpretable, evidence-linked information alongside clinical context. We are preparing a pilot, with clinical usefulness still to be evaluated.
In development · Pilot study in preparationHOW IT FITS TOGETHER
Six steps connect a sample to an appointment. Neurabi builds the four in the middle; the laboratory and the appointment belong to the people around it.
A stool sample goes to a laboratory, which sequences it.
54 measurements arrive: bacterial types and gene-based processes, each as a share of the sample.
Each one is placed against a reference interval modelled for age, sex and body mass index.
Saved research is attached to each result, with its study design and its limits.
A clinician weighs every result and decides what to discuss. An assistant explains the sources; the clinician decides.
The released report is read together at the appointment, in plain language.
Machine learning helps make the measurements as accurate and clear as we can. One frozen model version is used, so a later sample can be compared with the same reference.
CONCEPT · RESEARCH REPORT
Our planned report structure brings observations, research comparisons and uncertainty into one conversation. Shown here as a concept, with example data.
Community composition and measured biological features.
Relevant studies, comparison populations and methods.
Uncertainty, missing information and questions for further study.
The report describes, compares and explains. Diagnosis and treatment decisions remain with the clinician.
THE CLINICAL WORKSPACE · PROTOTYPE
The clinical workspace is a working prototype. These are its real screens, photographed with example data. Every result, source and decision stays visible until the clinician releases the report.
Submissions by date, filtered by what needs review, a patient question or an update, with the patient record one click away.
Select a measurement to see its value against the reference interval, with less certain comparisons flagged.
Literature drafts cite saved sources, each labelled by study design and strength. Unverified designs are marked as such.
The assistant answers questions about the saved sources, with citations. It explains; the clinician decides.
Each selected result receives an explicit decision: approved, approved with edits, rejected, no action or further assessment.
Approve the plan, prepare the draft, preview the exact report, then release it. Every version is kept.
OUR FIRST RESEARCH FOCUS
Our initial research priorities are Alzheimer’s disease, Parkinson’s disease and multiple sclerosis. The exact pilot population and protocol are being developed.
We welcome conversations with neurologists, researchers and patient organisations about meaningful study endpoints, feasibility and responsible interpretation.
Discuss a research collaborationOUR JOURNEY
Four milestones, from the prototype that exists today to a service that would follow validation. Timing depends on research findings, partnerships and the necessary approvals.
The research method, the portal and clinician review have been built and tested with example data.
Agreeing the study protocol, laboratory arrangements and clinical input, and preparing for the required approvals.
Run the pilot once approved, with follow-up and repeat samples, to find out whether this is feasible and useful.
Further validation and any regulatory steps would come before a service could become available.